What was Avicanna’s price range in the past 12 months?
Avicanna lowest stock price was $0.15 and its highest was $0.53 in the past 12 months.
What is Avicanna’s market cap?
Currently, no data Available
When is Avicanna’s upcoming earnings report date?
Avicanna’s upcoming earnings report date is May 27, 2024 which is in 27 days.
How were Avicanna’s earnings last quarter?
Avicanna released its earnings results on Apr 02, 2024. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.02.
Avicanna’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avicanna have?
Avicanna has 87,687,800 shares outstanding.
What happened to Avicanna’s price movement after its last earnings report?
Avicanna reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10%.
Which hedge fund is a major shareholder of Avicanna?
Currently, no hedge funds are holding shares in AVCNF
Avicanna is an Ontario corporation focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products via its two main business segments, cultivation and R&D With two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna's cultivation activities. These companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including CBD and THC. Avicanna's research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna has engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto.